Strong Financial Performance
Cresco Labs reported $180 million in revenue with a 53% adjusted gross profit margin and a 29% adjusted EBITDA margin. Adjusted gross margin increased by 250 basis points, and EBITDA margin by 275 basis points year-over-year.
Record Operating Cash Flow
The company delivered $49 million in operating cash flow in the quarter and $103 million year-to-date, which is $41 million more than the previous year despite slightly lower revenue.
Strategic Market Position in Ohio
Cresco Labs achieved a top three branded market share position in Ohio, up 220 basis points year-over-year, due to improved efficiencies and strong branding.
Wholesale Excellence
Cresco Labs holds the number one overall share positions in branded products in Illinois, Pennsylvania, and Massachusetts, while reducing cost of goods sold by 11%.
Retail Platform Growth
Improved retail fair share to 1.4 times on average across markets, the highest in Cresco Labs' history, with a 76% sales increase year-over-year after converting Pennsylvania dispensaries to the Sunnyside platform.